Publications by authors named "A Sacaan"

Claim this Profile
D
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor.
Gary M Gallego, Cynthia Palmer, Suvi Orr, Louise Bernier, Ping Chen, Aida Sacaan

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety.
Cynthia L Palmer, Britton Boras, Bernadette Pascual, Na Li, Danan Li, Aida Sacaan

Cancer Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the dTAG system in vivo to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilities.
Paul Yenerall, Tae Sung, Kiran Palyada, Jessie Qian, Seda Arat, Aida Sacaan

Toxicol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab Ozogamicin Treatment Results in Decreased Proliferation and Differentiation of Human Megakaryocytes but Does Not Inhibit Mature Platelet Function.
Allison Vitsky, Aida Sacaan, Wenyue Hu, Martin Finkelstein, William Reagan

Toxicol Pathol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-clinical combination toxicology studies: strategy, examples and future perspective.
Aida Sacaan, Satoko Nonaka Hashida, Nasir K Khan

J Toxicol Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis